Overview

CC-223 and Ketoconazole Drug-Drug Interaction Study

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This is a single-center open-label study to compare how CC-223 (the study drug being investigated) interacts with the drug ketoconazole.
Phase:
Phase 1
Details
Lead Sponsor:
Celgene
Celgene Corporation
Treatments:
Ketoconazole